Back
Dermata Therapeutics Stock Price Chart
Could This Stock Under $5 Be Your Biggest Opportunity?
Click here to learn more.
Buy
55
DRMA
Dermata Therapeutics
Last Price:
$1.42
Seasonality Move:
-39.31%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRMA is experiencing buying pressure, which is a positive indicator for future bullish movement.
Dermata Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.3 | Buy |
| 20-day SMA: | 1.24 | Buy |
| 50-day SMA: | 1.25 | Buy |
| 200-day SMA: | 2.67 | Sell |
| 8-day EMA: | 1.31 | Buy |
| 20-day EMA: | 1.25 | Buy |
| 50-day EMA: | 1.31 | Buy |
| 200-day EMA: | 5.04 | Sell |
Dermata Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.03 | Buy |
| Relative Strength Index (14 RSI): | 60.22 | Buy |
| Chaikin Money Flow: | 105890 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.1 - 1.34) | Buy |
| Bollinger Bands (100): | (1.16 - 1.78) | Sell |
Dermata Therapeutics Technical Analysis
| Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 18 | 19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Dermata Therapeutics Stock
Is Dermata Therapeutics Stock a Buy?
-
Dermata Therapeutics share price is 1.39 while DRMA 8-day simple moving average is 1.30, which is a Buy signal.
-
The stock price of DRMA is 1.39 while Dermata Therapeutics 20-day SMA is 1.24, which makes it a Buy.
-
Dermata Therapeutics 50-day simple moving average is 1.25 while DRMA share price is 1.39, making it a Buy technically.
-
DRMA stock price is 1.39 and Dermata Therapeutics 200-day simple moving average is 2.67, creating a Sell signal.
DRMA Technical Analysis vs Fundamental Analysis
Buy
55
Dermata Therapeutics (DRMA)
is a Buy
Is Dermata Therapeutics a Buy or a Sell?
-
Dermata Therapeutics stock is rated a BuyThe current Dermata Therapeutics [DRMA] share price is $1.39. The Score for DRMA is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
Dermata Therapeutics Stock Info
Market Cap:
2.8M
Price in USD:
1.39
Share Volume:
126.1K
Dermata Therapeutics 52-Week Range
52-Week High:
13.35
52-Week Low:
1.00
Buy
55
Dermata Therapeutics (DRMA)
is a Buy
Dermata Therapeutics Share Price Forecast
-
What is the Dermata Therapeutics stock price today?The Dermata Therapeutics stock price is 1.39 USD today.
-
Will DRMA stock go up or go down?Dermata Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Dermata Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Dermata Therapeutics is not overvalued.
Is Dermata Therapeutics Stock a Buy?
-
Dermata Therapeutics share price is 1.39 while DRMA 8-day exponential moving average is 1.31, which is a Buy signal.
-
The stock price of DRMA is 1.39 while Dermata Therapeutics 20-day EMA is 1.25, which makes it a Buy.
-
Dermata Therapeutics 50-day exponential moving average is 1.31 while DRMA share price is 1.39, making it a Buy technically.
-
DRMA stock price is 1.39 and Dermata Therapeutics 200-day simple moving average is 5.04, creating a Sell signal.
Technical Analysis of Dermata Therapeutics
Should I short Dermata Therapeutics stock?
-
DRMA Moving Average Covergence Divergence (MACD) indicator is 0.03, suggesting Dermata Therapeutics is a Buy
-
Dermata Therapeutics Relative Strength Index (RSI) is 60.22, which suggest Dermata Therapeutics is overbought
-
The Bollinger Bands (25) for Dermata Therapeutics is (1.1 - 1.34), which suggest Dermata Therapeutics is a Sell
-
The Bollinger Bands (100) for Dermata Therapeutics is (1.16 - 1.78), which suggest Dermata Therapeutics is a Sell
* Dermata Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.